The Role of Pharmacogenomics in Postoperative Pain Management

Overview

Journal Methods Mol Biol

Specialty Molecular Biology

Date 2022 Sep 6

PMID 36068475

Authors

E Paylor Sachtleben

Kelsey Rooney

Hannah Haddad

Victoria L Lassiegne

Megan Boudreaux

Elyse M Cornett

Alan D Kaye

Affiliations

Soon will be listed here.

Abstract

Pharmacogenomics can improve pain management by considering individual variations in pain perception and susceptibility and sensitivity to medicines related to genetic diversity. Due to the subjective nature of pain and the fact that people respond differently to medicines, it can be challenging to develop a consistent and successful regimen for pain disorders. Numerous factors influence the outcome of pain treatment programs, but two stand out: altered perception of pain and varying responsiveness to analgesic medicines. Numerous polymorphisms in genes such as CYP2D6, OPRM1, and ABCB1 have been identified, culminating in a heterogeneous response to pain medication in people who have these genetic polymorphisms. Improved treatment regimens that factor in pharmacogenetic differences in patients would help reduce the risk of opioid dependency and help effectively treat postoperative pain.

References

Cornett E, Carroll Turpin M, Pinner A, Thakur P, Selvan Gnana Sekaran T, Siddaiah H . Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism. Curr Oncol Rep. 2020; 22(2):18. DOI: 10.1007/s11912-020-0865-4. View

Chaturvedi R, Alexander B, ACourt A, Waterman R, Burton B, Urman R . Genomics testing and personalized medicine in the preoperative setting: Can it change outcomes in postoperative pain management?. Best Pract Res Clin Anaesthesiol. 2020; 34(2):283-295. DOI: 10.1016/j.bpa.2020.05.008. View

Aroke E, Kittelsrud J . Pharmacogenetics of Postoperative Pain Management: A Review. AANA J. 2020; 88(3):229-236. View

Nahin R . Estimates of pain prevalence and severity in adults: United States, 2012. J Pain. 2015; 16(8):769-80. PMC: 4562413. DOI: 10.1016/j.jpain.2015.05.002. View

Brekke M, Hjortdahl P, Kvien T . Severity of musculoskeletal pain: relations to socioeconomic inequality. Soc Sci Med. 2002; 54(2):221-8. DOI: 10.1016/s0277-9536(01)00018-1. View

Fischer S, Doerr J, Strahler J, Mewes R, Thieme K, Nater U . Stress exacerbates pain in the everyday lives of women with fibromyalgia syndrome--The role of cortisol and alpha-amylase. Psychoneuroendocrinology. 2015; 63:68-77. DOI: 10.1016/j.psyneuen.2015.09.018. View

Coulbault L, Beaussier M, Verstuyft C, Weickmans H, Dubert L, Tregouet D . Environmental and genetic factors associated with morphine response in the postoperative period. Clin Pharmacol Ther. 2006; 79(4):316-24. DOI: 10.1016/j.clpt.2006.01.007. View

Osteras B, Sigmundsson H, Haga M . Perceived stress and musculoskeletal pain are prevalent and significantly associated in adolescents: an epidemiological cross-sectional study. BMC Public Health. 2015; 15:1081. PMC: 4619092. DOI: 10.1186/s12889-015-2414-x. View

10.

Periasamy S, Poovathai R, Pondiyadanar S . Influences of gender on postoperative morphine consumption. J Clin Diagn Res. 2015; 8(12):GC04-7. PMC: 4316269. DOI: 10.7860/JCDR/2014/10770.5319. View

11.

Si H, Yang T, Zeng Y, Zhou Z, Pei F, Lu Y . Correlations between inflammatory cytokines, muscle damage markers and acute postoperative pain following primary total knee arthroplasty. BMC Musculoskelet Disord. 2017; 18(1):265. PMC: 5473999. DOI: 10.1186/s12891-017-1597-y. View

12.

Zhang J, An J . Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007; 45(2):27-37. PMC: 2785020. DOI: 10.1097/AIA.0b013e318034194e. View

13.

Bair M, Robinson R, Katon W, Kroenke K . Depression and pain comorbidity: a literature review. Arch Intern Med. 2003; 163(20):2433-45. DOI: 10.1001/archinte.163.20.2433. View

14.

Song T, Cho S, Kim W, Yang K, Yun C, Chu M . Anxiety and Depression in Tension-Type Headache: A Population-Based Study. PLoS One. 2016; 11(10):e0165316. PMC: 5082613. DOI: 10.1371/journal.pone.0165316. View

15.

Davies K, Silman A, Macfarlane G, Nicholl B, Dickens C, Morriss R . The association between neighbourhood socio-economic status and the onset of chronic widespread pain: results from the EPIFUND study. Eur J Pain. 2008; 13(6):635-40. PMC: 2701988. DOI: 10.1016/j.ejpain.2008.07.003. View

16.

Nielsen C, Stubhaug A, Price D, Vassend O, Czajkowski N, Harris J . Individual differences in pain sensitivity: genetic and environmental contributions. Pain. 2007; 136(1-2):21-9. DOI: 10.1016/j.pain.2007.06.008. View

17.

Mossey J . Defining racial and ethnic disparities in pain management. Clin Orthop Relat Res. 2011; 469(7):1859-70. PMC: 3111792. DOI: 10.1007/s11999-011-1770-9. View

18.

Green C, Anderson K, Baker T, Campbell L, Decker S, Fillingim R . The unequal burden of pain: confronting racial and ethnic disparities in pain. Pain Med. 2003; 4(3):277-94. DOI: 10.1046/j.1526-4637.2003.03034.x. View

19.

Reyes-Gibby C, Aday L, Todd K, Cleeland C, Anderson K . Pain in aging community-dwelling adults in the United States: non-Hispanic whites, non-Hispanic blacks, and Hispanics. J Pain. 2006; 8(1):75-84. PMC: 1974880. DOI: 10.1016/j.jpain.2006.06.002. View

20.

Agundez J, Blanca M, Cornejo-Garcia J, Garcia-Martin E . Pharmacogenomics of cyclooxygenases. Pharmacogenomics. 2015; 16(5):501-22. DOI: 10.2217/pgs.15.6. View

21.

Kaye A, Garcia A, Hall O, Jeha G, Cramer K, Granier A . Update on the pharmacogenomics of pain management. Pharmgenomics Pers Med. 2019; 12:125-143. PMC: 6613192. DOI: 10.2147/PGPM.S179152. View